Passive Stretching for Peripheral Arterial Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how passive stretching of the calf muscles can improve leg pain and walking ability in people with peripheral artery disease (PAD). PAD often causes pain during walking due to reduced blood flow, partly because of low nitric oxide levels. The study will examine how stretching affects inflammation and heart health, and whether combining it with dietary nitrate (such as nitrate-rich beetroot juice) can provide additional benefits. Suitable candidates for this trial have had PAD for at least three months, experience leg pain when walking, and have an ankle-brachial index of 0.90 or less, indicating reduced blood flow to the legs. Participants should not have engaged in regular exercise or undergone cardiovascular rehab in the past three months. As a Phase 2 trial, this research focuses on measuring the treatment's effectiveness in an initial, smaller group, offering participants a chance to contribute to important findings.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that gently stretching the calf muscles can be safe and helpful for people with peripheral artery disease (PAD). Earlier studies found that stretching improved blood flow and walking ability without causing serious side effects. Participants in these studies handled the stretching well, suggesting it is a safe option.
No major problems were reported, indicating that this treatment is safe. Additionally, stretching can help blood vessels become stronger during exercise, enhancing its safety.
This treatment is already in an advanced trial phase, indicating confidence in its safety. Overall, gentle stretching appears to be a well-tolerated and promising approach for PAD.12345Why are researchers excited about this trial?
Researchers are excited about passive stretching as a treatment for Peripheral Arterial Disease (PAD) because it offers a non-invasive way to improve blood flow and reduce inflammation. Unlike traditional treatments for PAD, which often include medications or surgical interventions to improve circulation, passive stretching targets the calf muscles directly. This method may enhance functional walking capacity by promoting muscle flexibility and circulation without the need for drugs or surgery. This makes it an appealing option for those looking for gentler, side-effect-free alternatives.
What evidence suggests that passive stretching and dietary nitrate could be effective for peripheral artery disease?
Research shows that gently stretching the calf muscles can increase blood flow and help people with peripheral artery disease (PAD) walk better. In this trial, participants will undergo passive stretching of the calf muscles to assess its effects on inflammation and functional walking capacity. Studies have found that this type of stretching improves the health of blood vessels. In older adults with stable PAD symptoms, passive stretching led to better walking ability. This treatment raises levels of nitric oxide, a substance that helps blood vessels relax and improves circulation. Overall, passive stretching seems promising for enhancing physical function in people with PAD.12346
Who Is on the Research Team?
Jacob T Caldwell, Ph.D.
Principal Investigator
Assistant Professor
Are You a Good Fit for This Trial?
This trial is for individuals with Peripheral Arterial Disease (PAD), which causes leg pain and difficulty walking due to poor blood flow. Participants should be interested in exploring non-drug treatments like stretching and dietary changes to improve their condition.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo passive stretching of the calf muscles 5 days per week for 12 weeks, combined with dietary nitrate to enhance walking capacity
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of functional capacity, inflammatory markers, and vascular function
What Are the Treatments Tested in This Trial?
Interventions
- Dietary Nitrate
- Passive Stretching
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, La Crosse
Lead Sponsor